NCT07033663View on ClinicalTrials.gov

Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 1, 2027

Study Completion Date

May 1, 2028

Conditions
Pregnancy RelatedImmune-mediated Diseases
Interventions
DRUG

Monoclonal antibody

non-intervention. Drug used in clinical practice as per practitioner decision

Trial Locations (3)

08950

RECRUITING

Hospital Sant Joan de Déu, Esplugues de Llobregat

08035

RECRUITING

Hospital Clínic de Barcelona, Barcelona

RECRUITING

Hospital Universitari Vall d'Hebrón, Barcelona

All Listed Sponsors
collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Hospital Vall d'Hebron

OTHER

lead

Fundació Sant Joan de Déu

OTHER